In response to the chronic Aβ deposition, in AD, microglial cells are persistently activated (Prinz et al., 2011) and result in increased interleukin-1β (IL-1β) levels (Lucin and Wyss-Coray, 2009). Here, IL1B is linked to Alzheimer disease.